Navigation Links
Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinson's Disease at International Neuromodulation Society 10th World Congress
Date:5/26/2011

ble, it may be unable to sustain profitability.
  • At March 31, 2011, the Company had cash and cash equivalents of approximately $5.4 million. Based on its cash flow projections, the Company will need additional financing to carry out its planned business activities and plan of operations after October 31, 2011 and to repay the promissory notes issued in 2010 as of said date. Accordingly, there is substantial doubt as to the Company's ability to continue as a going concern. The Company is currently seeking to raise funds, through public or private equity offerings, debt financings or corporate collaboration and licensing arrangements, sufficient to finance its ongoing operations.  The Company does not know whether additional financing will be available when needed, or if available, will be on acceptable or favorable terms to it or its stockholders.
  • The Company will need to conduct future clinical trials for the treatment of Parkinson's disease using the Company's NLX technology. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversely affected and the business may not succeed.
  • There is no assurance as to when, or if, the Company will be able to successfully receive approval from the FDA on its Investigational New Drug Application to commence a Phase 1 clinical trial for the treatment of epilepsy.
  • There is no assurance as to when, or if, the Company will be able to successfully complete the required preclinical testing of its gene therapy for the treatment of depression or Huntington's disease to enable it to file an Investigational New Drug Application with the FDA for permission to begin a Phase 1 clinical trial or that, if filed, such permission will be granted.

  • Other factors and assumptions not identified above could also cause the actual results to differ materially from those set forth in the forward-looking state
    '/>"/>

    SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
    2. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
    3. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
    4. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
    5. GeoVax Presents Data at AIDS Vaccine 2008 Conference
    6. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
    7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
    8. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
    9. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
    10. Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
    11. AmeriCares Presents Power of Partnership Award to Baxter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... , July 2, 2015 ... Bio-tech procurement company Amici Procurement has chosen Microsoft ... help it move to Office 365.      ... provides small to medium-sized companies in the bio-tech sector ... aspects of the purchasing cycle to help them obtain ...
    (Date:7/1/2015)... RESEARCH TRIANGLE PARK, N.C. and ... -- Leading agricultural research firm AgBiome, and Genective, key ... partnership to accelerate the discovery of new generations ... new traits for insect control to counter the ... to partner with Genective, aligning AgBiome,s unique insect ...
    (Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
    (Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
    Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2AgBiome and Genective collaborate to create novel insect-resistant crops 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4
    ... Mich., Dec. 18 Neogen Corporation (Nasdaq: NEOG ) ... of FY 2010, which ended Nov. 30, increased 18% from ... split effective Dec. 15, net income in the quarter rose ... Neogen,s second quarter net income of $4,610,000 set another quarterly ...
    ... , , , NEW HAVEN, ... of web-enabled database software for biomedical researchers, has been ... a working, web-enabled database software prototype that can be ... and is easy to use. , The National Science ...
    ... , - Therapure Biopharma to perform fill/finish of nimotuzumab ... Allan, Chairman and CEO of YM BioSciences Inc. and ... today announced the signing of an agreement under which ... nimotuzumab, the humanized monoclonal antibody licensed to YM,s majority-owned ...
    Cached Biology Technology:Neogen Reports 18% Increase in Net Income 2Neogen Reports 18% Increase in Net Income 3Neogen Reports 18% Increase in Net Income 4Neogen Reports 18% Increase in Net Income 5Neogen Reports 18% Increase in Net Income 6Neogen Reports 18% Increase in Net Income 7Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 2Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 3YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 2YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 3YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 4
    (Date:6/17/2015)... June 17, 2015  Crossmatch™, a leading provider ... its U.are.U ® 4500 fingerprint readers have ... Eateries, Inc., a San Jose, CA ... increase security, improve accountability and reduce fraud at ... non-repudiable identity confirmation for employee sign in and ...
    (Date:6/16/2015)... -- With the increasing number and severity of data breaches ... recent compromise of Federal employee data from OPM,s ... government agencies. HYPR Corp. announced today that ... has been submitted for testing and approval of Federal ... tamper proofing. The proliferation of security ...
    (Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... communicated that it will amount to at least 340 MSEK ... to the rapid increase in market growth and orders received ... communicated guidance that revenue for 2015 will exceed 1,500 MSEK ... to approximately 2,200 MSEK. Due to receipt of ...
    Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
    ... collaboration with the Technical University of Braunschweig (TUBS), Germany ... autonomous unmanned aerial vehicles (UAVs) in Antarctica. This is ... in the Antarctic and the successful flights open up ... the harshest and remotest environment on Earth. Dr ...
    ... study, researchers taking advantage of improvements in satellite sensor ... of pollution from East Asian forest fires, urban exhaust, ... North America. China, the worlds most populated country, ... urban areas, and considerable expansion in automobile use over ...
    ... Human diseases and social networks would seem to ... of these two lies a network,communities within the ... In a recent paper in Physical Review E ... computer science and engineering and of genetics, and ...
    Cached Biology News:Unmanned aerial vehicles mark robotic first for British Antarctic Survey 2NASA satellite measures pollution from east Asia to North America 2NASA satellite measures pollution from east Asia to North America 3Algorithm finds the network -- for genes or the Internet 2Algorithm finds the network -- for genes or the Internet 3
    This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
    ... Analysis Note: Protein determined by ... 3.2 M (NH 4 ) ... 7.0 Preparation Note: Affinity purified ... suspension • Additives: MgCl 2 ...
    ... miRNA Bioarray Essentials Kit provides all the necessary ... of the mir Vana miRNA Bioarrays when ... using Ambions mir Vana miRNA Labeling Kit. ... (Bioarray ID BA10001) that should be spiked into ...
    ... IT siRNA Tracker Intracellular Localization Kit ... straight forward approach to directly label ... in an efficient yet non-destructive manner, ... localization and functional inhibition of target ...
    Biology Products: